HCW Biologics (HCWB) Other Gross PP&E Adjustments (2020 - 2024)
HCW Biologics (HCWB) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with $13.1 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Other Gross PP&E Adjustments changed 0.22% year-over-year to $13.1 million, compared with a TTM value of $13.1 million through Dec 2024, changed 0.22%, and an annual FY2024 reading of $13.1 million, changed 0.22% over the prior year.
- Other Gross PP&E Adjustments was $13.1 million for Q4 2024 at HCW Biologics, roughly flat from $13.1 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $13.1 million in Q4 2024 and bottomed at -$306300.0 in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is $3.9 million, with a median of -$69624.0 recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments skyrocketed 364.5% in 2022, then grew 0.22% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $2.7 million in 2020, then increased by 1.74% to $2.8 million in 2021, then soared by 364.5% to $12.9 million in 2022, then increased by 1.6% to $13.1 million in 2023, then grew by 0.22% to $13.1 million in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for HCWB at $13.1 million in Q4 2024, $13.1 million in Q4 2023, and -$69624.0 in Q3 2023.